New laboratory markers for the management of rheumatoid arthritis patients

被引:3
作者
Foti, Daniela P. [2 ]
Greco, Marta [2 ]
Palella, Eleonora [2 ]
Gulletta, Elio [1 ]
机构
[1] Dept Hlth Sci, I-88100 Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Clin Pathol Unit, Catanzaro, Italy
关键词
evidence-based laboratory medicine (EBLM); immunopathogenesis; laboratory assay; rheumatoid arthritis; NATURAL-KILLER-CELLS; PROTEOMIC ANALYSIS; AUTOIMMUNE; PATHOGENESIS; CYTOKINES; CLASSIFICATION; ASSOCIATION; CHEMOKINES; ANTIBODIES; PROTEINS;
D O I
10.1515/cclm-2014-0383
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Rheumatoid arthritis, the most prominent of systemic autoimmune rheumatic diseases, represents an important social health problem. Recent insights into the immunopathogenic mechanism of this complex and multiform illness might open new perspectives for a more appropriate laboratory approach. In this review we focus on the most relevant pathogenetic mechanism; indicating the laboratory biomarkers specifically linked to early diagnosis, prognosis, evolutive aspects of the disease, and therapeutic efficacy. Evidence based on laboratory medicine could provide the best outcome for patients.
引用
收藏
页码:1729 / 1737
页数:9
相关论文
共 66 条
[1]   Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity [J].
Aletaha, Daniel ;
Alasti, Farideh ;
Smolen, Josef S. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (06) :875-880
[2]   Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis [J].
Ally, Mahmood M. T. M. ;
Hodkinson, Bridget ;
Meyer, Pieter W. A. ;
Musenge, Eustasius ;
Tikly, Mohammed ;
Anderson, Ronald .
MEDIATORS OF INFLAMMATION, 2013, 2013
[3]  
Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO
[4]  
2-9
[5]   Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases [J].
Antonelli, Alessandro ;
Ferrari, Silvia Martina ;
Giuggioli, Dilia ;
Ferrannini, Ele ;
Ferri, Clodoveo ;
Fallahi, Poupak .
AUTOIMMUNITY REVIEWS, 2014, 13 (03) :272-280
[6]   Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden [J].
Arlestig, Lisbeth ;
Mullazehi, Mohammed ;
Kokkonen, Heidi ;
Rocklov, Joacim ;
Ronnelid, Johan ;
Dahlqvist, Solbritt Rantapaa .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) :825-829
[7]   Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study [J].
Bakker, Marije F. ;
Cavet, Guy ;
Jacobs, Johannes W. G. ;
Bijlsma, Johannes W. J. ;
Haney, Douglas J. ;
Shen, Yijing ;
Hesterberg, Lyndal K. ;
Smith, Dustin R. ;
Centola, Michael ;
van Roon, Joel A. G. ;
Lafeber, Floris P. J. G. ;
Welsing, Paco M. J. .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (10) :1692-1697
[8]   Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation lmmunoenzymatic methods for the detection of antibodies to citrullinated proteins [J].
Bizzaro, Nicola ;
Tonutti, Elio ;
Tozzoli, Renato ;
Villalta, Danilo .
CLINICAL CHEMISTRY, 2007, 53 (08) :1527-1533
[9]   Emerging cell and cytokine targets in rheumatoid arthritis [J].
Burmester, Gerd R. ;
Feist, Eugen ;
Doerner, Thomas .
NATURE REVIEWS RHEUMATOLOGY, 2014, 10 (02) :77-88
[10]   Matrix metalloproteinases: Role in arthritis [J].
Burrage, PS ;
Mix, KS ;
Brinckerhoff, CE .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 :529-543